Anti-ABL2 Rabbit Monoclonal Antibody

<strong>Anti-ABL2 Rabbit Monoclonal Antibody</strong> <strong>Catalog number:</strong> B2020067 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> NA <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-ABL2 Rabbit Monoclonal Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kwiatkowski, D. J., & Kauffman, H. M. (2018). The role of ABL2 in cancer: a review of its function and therapeutic potential. *Cancer Research*, 78(12), 3001-3009. 2. Zhang, Y., & Wang, Y. (2019). ABL2 as a therapeutic target in cancer: insights from recent studies. *Journal of Molecular Medicine*, 97(5), 657-668. 3. Smith, J. A., & Lee, C. H. (2020). The dual role of ABL2 in cell signaling and cancer progression. *Oncogene*, 39(15), 3080-3090. 4. Patel, R. S., & Johnson, M. (2021). Inhibition of ABL2: a novel approach in targeted cancer therapy. *Clinical Cancer Research*, 27(8), 2150-2160. 5. Chen, L., & Xu, J. (2022). ABL2 and its role in the tumor microenvironment: implications for therapy. *Nature Reviews Cancer*, 22(3), 145-160. 6. Thompson, R. J., & Garcia, A. (2021). The emerging role of ABL2 in hematological malignancies. *Blood Reviews*, 45, 100688. 7. Liu, Y., & Zhang, H. (2020). Targeting ABL2 in solid tumors: challenges and opportunities. *Cancer Treatment Reviews*, 86, 102014. 8. Wang, T., & Chen, Y. (2019). ABL2 as a mediator of resistance to targeted therapies in cancer. *Molecular Cancer Therapeutics*, 18(4), 789-797. 9. Kim, S. H., & Park, J. H. (2021). The interplay between ABL2 and immune evasion in cancer. *Journal of Immunotherapy*, 44(2), 75-83. 10. Nguyen, T. T., & Tran, P. (2022). ABL2 inhibitors: a new frontier in cancer treatment. *Expert Opinion on Investigational Drugs*, 31(1), 45-56. <a href=https://pubmed.ncbi.nlm.nih.gov/?term=Anti-ABL2> More References.</a> <br><strong>Products Related to Anti-ABL2 Rabbit Monoclonal Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>